Santos, Tabata Maruyama dos 
; Leick, Edna Aparecida ; Martins, Milton de Arruda
Source: Frontiers in physiology. Unidade: FM
Subjects: ASMA, INTERLEUCINAS, ANTICORPOS MONOCLONAIS, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Tabata Maruyama dos e LEICK, Edna Aparecida e MARTINS, Milton de Arruda. Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma. Frontiers in physiology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphys.2018.01183. Acesso em: 28 jun. 2024.APA
Santos, T. M. dos, Leick, E. A., & Martins, M. de A. (2018). Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma. Frontiers in physiology, 9. doi:10.3389/fphys.2018.01183NLM
Santos TM dos, Leick EA, Martins M de A. Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma [Internet]. Frontiers in physiology. 2018 ; 9[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fphys.2018.01183Vancouver
Santos TM dos, Leick EA, Martins M de A. Effect of Anti-IL17 Antibody Treatment Alone and in Combination With Rho-Kinase Inhibitor in a Murine Model of Asthma [Internet]. Frontiers in physiology. 2018 ; 9[citado 2024 jun. 28 ] Available from: https://doi.org/10.3389/fphys.2018.01183
